Table 7.
Frequency of low serum concentrations of collectin CL-LK in investigated groups (for MM and LYMPH groups: data from sample 1, taken before chemotherapy).
| Group (n) | % of concentrations < 242 ng/ml | Statistical significance (vs. C) |
|---|---|---|
| C (227) | 9.7 | - |
| MM (187)* | 2.1 | p = 0.002; OR 0.2; 95% CI (0.07-0.6) |
| MM-A (41) | 0 | p = 0.031; OR 0.11; 95% CI (0.007-1.85) |
| MM-B (30) | 0 | p = 0.087 |
| MM-A+B (71) | 0 | p = 0.003; OR 0.06; 95% CI (0.004-1.07) |
| MM-C (38) | 0 | p = 0.052 |
| MM-D (78) | 5.1 | p = 0.25 |
| LYMPH (116)* | 7.8 | p = 0.69 |
| LYMPH-A (32) | 9.4 | p = 1 |
| LYMPH-B (38) | 7.9 | p = 1 |
| LYMPH-A+B (70) | 8.6 | p = 1 |
| LYMPH-C (10) | 20 | p = 0.27 |
| LYMPH-D (36) | 2.8 | p = 0.22 |
*
MM-A, LYMPH-A: patients who experienced infections with proven bacteremia; MM-B, LYMPH-B: patients who experienced infections with no bacteremia; MM-C, LYMPH-C: patients who experienced febrile neutropenia; MM-D, LYMPH-D: patients who experienced none of afore-mentioned complications during hospital stay.